scispace - formally typeset
C

Clement Ma

Researcher at Harvard University

Publications -  105
Citations -  5736

Clement Ma is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Prostate brachytherapy. The author has an hindex of 33, co-authored 102 publications receiving 4814 citations. Previous affiliations of Clement Ma include University of Michigan & Centre for Addiction and Mental Health.

Papers
More filters
Journal ArticleDOI

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +349 more
- 11 Jul 2016 - 
TL;DR: In this paper, the authors performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing for 12,940 individuals from five ancestry groups.

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +300 more
TL;DR: Large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes, but most fell within regions previously identified by genome-wide association studies.
Journal ArticleDOI

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Robert A. Scott, +216 more
- 01 Nov 2017 - 
TL;DR: This article conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel.
Journal ArticleDOI

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

Kyle J. Gaulton, +261 more
- 01 Dec 2015 - 
TL;DR: This paper performed fine mapping of 39 established type 2 diabetes (T2D) loci in 27,206 cases and 57,574 controls of European ancestry, and identified 49 distinct association signals at these loci including five mapping in or near KCNQ1.
Journal ArticleDOI

Comparison of Health-Related Quality of Life 5 Years After SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial

TL;DR: Although treatment allocation was random in only 19%, all patients received identical information in a multidisciplinary setting before selecting RP, BT, or random assignment and showed an advantage for BT in urinary and sexual domains and in patient satisfaction.